This update will be published weekly at 12pm GMT on Mondays and aims to provide clinicians and the public with an overview of the latest data, guidelines, key publications and policy around COVID-19, with links to essential resources and information.

Cardiology Meetings in COVID-19: What’s worked so far? What hasn’t? Roxana Mehran hears from Ron Blankstein and Asif Qasim.

This update will be published weekly at 12pm GMT on Mondays and aims to provide clinicians and the public with an overview of the latest data, guidelines, key publications and policy around COVID-19, with links to essential resources and information.

Digoxin improved some measures of quality of life at 12 months and was associated with greater reductions in NYHA class and NT-proBNP. Digoxin was also associated with fewer adverse events compared with beta-blockers.

This update will be published weekly at 12pm GMT on Mondays and aims to provide clinicians and the public with an overview of the latest data, guidelines, key publications and policy around COVID-19, with links to essential resources and information.

This update will be published weekly at 12pm GMT on Mondays and aims to provide clinicians and the public with an overview of the latest data, guidelines, key publications and policy around COVID-19, with links to essential resources and information.

Non-alcoholic liver disease (NAFLD) is hepatic steatosis in a patient without a secondary cause for fat accumulation within the liver. What are the clinical manifestations of NAFLD and how should we manage these patients?

This update will be published weekly on Mondays and aims to provide clinicians and the public with an overview of the latest data, guidelines, key publications and policy around COVID-19, with links to essential resources and information.

In LMIC maternal and perinatal mortality rates are still a concern. How can we support women through pregnancy and perinatal care amidst a COVID-19 pandemic?